Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Matthias Fante"'
Autor:
Sabine Kayser, Chiara Sartor, Marlise R. Luskin, Jonathan Webster, Fabio Giglio, Nydia Panitz, Andrew M. Brunner, Matthias Fante, Christoph Lutz, Daniel Wolff, Anthony D. Ho, Mark J. Levis, Richard F. Schlenk, Cristina Papayannidis
Publikováno v:
Haematologica, Vol 107, Iss 9 (2022)
Acute lymphoblastic leukemia (ALL) can relapse in the extramedullary compartment, with or without medullary involvement. Response to treatment may be individual. We evaluated response to inotuzumab ozogamicin in 31 patients with relapsed/refractory B
Externí odkaz:
https://doaj.org/article/f86b6a61e1a74dddac2a7c3f1b432bb8
Autor:
Kathrin Renner, Christina Bruss, Annette Schnell, Gudrun Koehl, Holger M. Becker, Matthias Fante, Ayse-Nur Menevse, Nathalie Kauer, Raquel Blazquez, Lisa Hacker, Sonja-Maria Decking, Toszka Bohn, Stephanie Faerber, Katja Evert, Lisa Aigle, Sabine Amslinger, Maria Landa, Oscar Krijgsman, Elisa A. Rozeman, Christina Brummer, Peter J. Siska, Katrin Singer, Stefanie Pektor, Matthias Miederer, Katrin Peter, Eva Gottfried, Wolfgang Herr, Ibtisam Marchiq, Jacques Pouyssegur, William R. Roush, SuFey Ong, Sarah Warren, Tobias Pukrop, Philipp Beckhove, Sven A. Lang, Tobias Bopp, Christian U. Blank, John L. Cleveland, Peter J. Oefner, Katja Dettmer, Mark Selby, Marina Kreutz
Publikováno v:
Cell Reports, Vol 29, Iss 1, Pp 135-150.e9 (2019)
Summary: Tumor-derived lactic acid inhibits T and natural killer (NK) cell function and, thereby, tumor immunosurveillance. Here, we report that melanoma patients with high expression of glycolysis-related genes show a worse progression free survival
Externí odkaz:
https://doaj.org/article/ca9683bbded745c68d1cf4f71ab912e4
Autor:
Kathrin Renner, Anton Seilbeck, Nathalie Kauer, Ines Ugele, Peter J. Siska, Christina Brummer, Christina Bruss, Sonja-Maria Decking, Matthias Fante, Astrid Schmidt, Kathrin Hammon, Katrin Singer, Sebastian Klobuch, Simone Thomas, Eva Gottfried, Katrin Peter, Marina Kreutz
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
The accelerated metabolism of tumor cells, inevitable for maintaining high proliferation rates, is an emerging target for tumor therapy. Increased glucose and lipid metabolism as well as mitochondrial activity have been shown in solid tumors but also
Externí odkaz:
https://doaj.org/article/2a068e5a9f344f869bc511d67dced0cf
Autor:
Katharina M. Habenicht, Anna Bootz, Simon Schäfer, Ingrid Vasova, Matthias Fante, Andrea Schneider, Michael Rehli, Petra Hoffmann, Wolf Roesler, Matthias Edinger, Wolfgang Herr, Andreas Mackensen, Daniel Wolff, Julia Winkler, Thomas H. Winkler
Publikováno v:
Blood. 140:4776-4777
Autor:
Daniel Wolff, Wolfgang Herr, Martin Heidenreich, Daniela Weber, Matthias Edinger, Andreas Neubauer, Gabriel Afram, Matthias Fante, Stephan Mielke, Marius Dohse, Per Ljungman, Anna-Sophia Kattner, Tobias Wertheimer, Antonio Pérez Martínez, Barbara Holler, Ernst Holler
Publikováno v:
Annals of Hematology
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of abatacept for cGvHD the
Autor:
Sabine, Kayser, Chiara, Sartor, Marlise R, Luskin, Jonathan, Webster, Fabio, Giglio, Nydia, Panitz, Andrew M, Brunner, Matthias, Fante, Christoph, Lutz, Daniel, Wolff, Anthony D, Ho, Mark J, Levis, Richard F, Schlenk, Cristina, Papayannidis
Publikováno v:
Haematologica. 107(9)
Acute lymphoblastic leukemia (ALL) can relapse in the extramedullary compartment, with or without medullary involvement. Response to treatment may be individual. We evaluated response to inotuzumab ozogamicin in 31 patients with relapsed/refractory B
Autor:
Tobias Wertheimer, Tobias Bergler, Daniela Weber, Barbara Holler, Daniel Wolff, Wolfgang Herr, Klemens Angstwurm, Ernst Holler, Matthias Edinger, Matthias Fante
Publikováno v:
Annals of Hematology
We retrospectively analyzed the safety and efficacy of cyclophosphamide (cyclo) for salvage treatment of chronic graft-versus-host disease (cGvHD) and cGvHD-associated (glomerulo-)nephritis at our center between 01/2010 and 11/2019. We identified 13
Autor:
Richard F. Schlenk, Cristina Papayannidis, Mark J. Levis, Sabine Kayser, Chiara Sartor, Jonathan Webster, Matthias Fante, Christoph Lutz, Marlise R. Luskin, Anthony D. Ho, Nydia Panitz, Andrew M. Brunner, Fabio Giglio, Daniel Wolff
Publikováno v:
Blood. 138:3404-3404
Background: Extramedullary B-cell acute lymphoblastic leukemia (EM-ALL) is a rare occurrence characterized by dismal outcome and no defined therapeutic approach. The monoclonal antibody inotuzumab ozogamicin (InO) is approved for treatment of CD22+ B
Publikováno v:
Bone Marrow Transplantation. 54:762-764
Autor:
Sabine Kayser, Chiara Sartor, Nydia Panitz, Matthias Fante, Christoph Lutz, Daniel Wolff, Anthony Ho, Cristina Papayannidis
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S206